Literature DB >> 14968110

Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300.

Cristiano Simone1, Peter Stiegler, Sonia-Vanina Forcales, Luigi Bagella, Antonio De Luca, Vittorio Sartorelli, Antonio Giordano, Pier Lorenzo Puri.   

Abstract

The balance between acetylation and deacetylation of histone and nonhistone proteins controls gene expression in a variety of cellular processes, with transcription being activated by acetyltransferases and silenced by deacetylases. We report here the formation and enzymatic characterization of a complex between the acetyltransferase p300 and histone deacetylases. The C/H3 region of p300 was found to co-purify deacetylase activity from nuclear cell extracts. A prototype of class I histone deacetylases, HDAC1, interacts with p300 C/H3 domain in vitro and in vivo. The p300-binding protein E1A competes with HDAC1 for C/H3 binding; and, like E1A, HDAC1 overexpression interferes with either activation of Gal4p300 fusion protein or p300-dependent co-activation of two C/H3-binding proteins, MyoD and p53. The exposure to deacetylase inhibitors could reverse the dominant-negative effect of a C/H3 fragment insulated from the rest of the molecule, on MyoD- and p53-dependent transcription, whereas inhibition by E1A was resistant to trichostatin A. These data support the hypothesis that association between acetyltransferases and deacetylases can control the expression of genes implicated in cellular growth and differentiation, and suggest that the dominant-negative effect of the p300 C/H3 fragment relies on deacetylase recruitment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14968110     DOI: 10.1038/sj.onc.1207327

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

2.  Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.

Authors:  Chong Wang; Hufeng Zhou; Yong Xue; Jun Liang; Yohei Narita; Catherine Gerdt; Amy Y Zheng; Runsheng Jiang; Stephen Trudeau; Chih-Wen Peng; Benjamin E Gewurz; Bo Zhao
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

3.  Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development.

Authors:  Lawryn H Kasper; Tomofusa Fukuyama; Michelle A Biesen; Fayçal Boussouar; Caili Tong; Antoine de Pauw; Peter J Murray; Jan M A van Deursen; Paul K Brindle
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 4.  Effects of histone deacetylase inhibitors on HIF-1.

Authors:  Dongming Liang; Xianguo Kong; Nianli Sang
Journal:  Cell Cycle       Date:  2006-09-13       Impact factor: 4.534

Review 5.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

6.  Quantitative dynamics of the link between cellular metabolism and histone acetylation.

Authors:  Adam G Evertts; Barry M Zee; Peter A Dimaggio; Michelle Gonzales-Cope; Hilary A Coller; Benjamin A Garcia
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

7.  Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.

Authors:  Donna M Fath; Xianguo Kong; Dongming Liang; Zhao Lin; Andrew Chou; Yubao Jiang; Jie Fang; Jaime Caro; Nianli Sang
Journal:  J Biol Chem       Date:  2006-03-15       Impact factor: 5.157

8.  Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.

Authors:  Carlo Serra; Daniela Palacios; Chiara Mozzetta; Sonia V Forcales; Ianessa Morantte; Meri Ripani; David R Jones; Keyong Du; Ulupi S Jhala; Cristiano Simone; Pier Lorenzo Puri
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

Review 9.  Role of HDAC1 in senescence, aging, and cancer.

Authors:  Danielle Willis-Martinez; Hunter W Richards; Nikolai A Timchenko; Estela E Medrano
Journal:  Exp Gerontol       Date:  2009-10-08       Impact factor: 4.032

10.  AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene.

Authors:  Christopher M J Williams; Angelo G Scibetta; J Karsten Friedrich; Monica Canosa; Chiara Berlato; Charlotte H Moss; Helen C Hurst
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.